MaxCyte to Report First Quarter 2025 Financial Results on May 7, 2025
MaxCyte (NASDAQ: MXCT), a cell-engineering platform technology company, has scheduled its first quarter 2025 financial results announcement for May 7th, 2025, after the U.S. market close. The company will host a conference call with management at 4:30 p.m. Eastern Time to discuss the quarterly performance.
Investors interested in participating in the earnings call must register online, preferably at least one day in advance. A live webcast and recording of the event will be accessible through the 'Events' section on MaxCyte's investor relations website.
MaxCyte (NASDAQ: MXCT), una società di tecnologia per l'ingegneria cellulare, ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per il 7 maggio 2025, dopo la chiusura del mercato statunitense. L'azienda ospiterà una conferenza telefonica con la direzione alle 16:30 ora orientale per discutere le performance trimestrali.
Gli investitori interessati a partecipare alla chiamata sugli utili devono registrarsi online, preferibilmente con almeno un giorno di anticipo. Una diretta web e la registrazione dell'evento saranno accessibili attraverso la sezione 'Eventi' sul sito web delle relazioni con gli investitori di MaxCyte.
MaxCyte (NASDAQ: MXCT), una empresa de tecnología de ingeniería celular, ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el 7 de mayo de 2025, después del cierre del mercado estadounidense. La empresa llevará a cabo una conferencia telefónica con la dirección a las 4:30 p.m. hora del Este para discutir el rendimiento trimestral.
Los inversores interesados en participar en la llamada de ganancias deben registrarse en línea, preferiblemente con al menos un día de anticipación. Una transmisión en vivo y una grabación del evento estarán disponibles a través de la sección 'Eventos' en el sitio web de relaciones con inversores de MaxCyte.
맥사이티 (NASDAQ: MXCT), 세포 공학 플랫폼 기술 회사가 2025년 1분기 재무 결과 발표를 2025년 5월 7일, 미국 시장 마감 후로 예정했습니다. 회사는 동부 표준시 오후 4시 30분에 경영진과 함께 분기 성과에 대해 논의하는 컨퍼런스 콜을 개최할 것입니다.
수익 전화에 참여하고자 하는 투자자는 온라인으로 등록해야 하며, 가급적 하루 전에는 등록하는 것이 좋습니다. 생중계 및 이벤트 녹화는 맥사이티의 투자자 관계 웹사이트의 '이벤트' 섹션을 통해 접근할 수 있습니다.
MaxCyte (NASDAQ: MXCT), une entreprise de technologie de plateforme d'ingénierie cellulaire, a programmé l'annonce de ses résultats financiers pour le premier trimestre 2025 pour le 7 mai 2025, après la fermeture du marché américain. L'entreprise tiendra une conférence téléphonique avec la direction à 16h30, heure de l'Est, pour discuter des performances trimestrielles.
Les investisseurs intéressés à participer à l'appel sur les bénéfices doivent s'inscrire en ligne, de préférence au moins un jour à l'avance. Un webinaire en direct et un enregistrement de l'événement seront accessibles via la section 'Événements' sur le site des relations avec les investisseurs de MaxCyte.
MaxCyte (NASDAQ: MXCT), ein Unternehmen für Zelltechnik-Plattformtechnologie, hat die Bekanntgabe seiner finanziellen Ergebnisse für das erste Quartal 2025 auf den 7. Mai 2025 nach Börsenschluss in den USA angesetzt. Das Unternehmen wird um 16:30 Uhr Eastern Time eine Telefonkonferenz mit dem Management abhalten, um die Quartalsleistung zu besprechen.
Investoren, die an der Gewinnanruf teilnehmen möchten, müssen sich online registrieren, idealerweise mindestens einen Tag im Voraus. Ein Live-Stream und eine Aufzeichnung der Veranstaltung werden über den Bereich 'Veranstaltungen' auf der Investor-Relations-Website von MaxCyte zugänglich sein.
- None.
- None.
ROCKVILLE, Md., April 10, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that it will release financial results for the first quarter 2025 after the U.S. market close on Wednesday, May 7th, 2025. Company management will host a conference call to discuss financial results at 4:30 p.m. Eastern Time.
Earnings Conference Call Details
Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the “Events” section of the MaxCyte website at https://investors.maxcyte.com/.
About MaxCyte
At MaxCyte, we pursue cell engineering excellence to maximize the potential of cells to improve patients’ lives. We have spent more than 25 years honing our expertise by building best-in-class platforms, perfecting the art of the transfection workflow, and venturing beyond today’s processes to innovate tomorrow’s solutions. Our ExPERT™ platform, which is based on our Flow Electroporation® technology, has been designed to support the rapidly expanding cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT family of products includes: four instruments, the ATx™, STx™, GTx™ and VLx ™; a portfolio of proprietary related processing assemblies or disposables; and software protocols, all supported by a robust worldwide intellectual property portfolio. By providing our partners with the right technology platform, as well as scientific, technical and regulatory support, we aim to guide them on their journey to transform human health. Learn more at maxcyte.com and follow us on X and LinkedIn.
MaxCyte Contacts:
US IR Adviser
Gilmartin Group
David Deuchler, CFA
+1 415-937-5400
ir@maxcyte.com
US Media Relations
Spectrum Science
Jordan Vines
jvines@spectrumscience.com
+1 540-629-3137
Nominated Adviser and Joint Corporate Broker
Panmure Liberum
Emma Earl / Freddy Crossley
Corporate Broking
Rupert Dearden
+44 (0)20 7886 2500
UK IR Adviser
ICR Healthcare
Mary-Jane Elliott
Chris Welsh
+44 (0)203 709 5700
maxcyte@icrhealthcare.com
FAQ
When will MaxCyte (MXCT) release its Q1 2025 earnings?
What time is MaxCyte's (MXCT) Q1 2025 earnings call?
How can investors join MaxCyte's (MXCT) Q1 2025 earnings call?
Where can I find the webcast of MaxCyte's (MXCT) Q1 2025 earnings call?
